Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atai Life Sciences N.V. (NQ: ATAI )

4.890 USD -0.170 (-3.36%)
Streaming Delayed Price Updated: 3:46 PM EST, Jan 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Atai Life Sciences N.V.

< Previous 1 2 3 4 Next >
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.60% at $0.19 GH Research (NASDAQ:GHRS) shares closed up 1.73% at ... 
Tags CMPS TRIP ALID
From Benzinga
Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 25.48% at $1.17 Mindset Pharma (OTC:MSSTF) shares closed up 15.85% at ... 
Tags Market News Benzinga Movers
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 6.45% at $1.98 Allied (OTC:ALID) shares closed up 2.27% at $1.80 Seelos ... 
Tags CYBN DMTTF GHRS
From Benzinga
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a... 
Tags Pharma/Biotech Stocks / Equities Market News
From TalkMarkets
Psychedelic Stock Gainers And Losers From January 21, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.18% at $17.19 LOSERS: Mindset Pharma (OTC:MSSTF) shares closed down ... 
Tags CMPS TRIP ALID
From Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 14.55% at $0.21 GH Research (NASDAQ:GHRS) shares closed up 3.35% at $16.99 Field ... 
Tags ALID TRIP CMPS
From Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.53% at ... 
Tags Market News Cannabis IGXT
From Benzinga
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelic Stock Gainers And Losers From January 18, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07 Intelgenx Technologies (OTC:IGXT) shares closed up 1.41% at ... 
Tags FTRP MSSTF Markets
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published ... 
Tags psychedelics Penny Stocks General
From Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2022
GAINERS: Allied (OTC:ALID) shares closed up 16.57% at $2.11 Filament Health (OTC:FLHLF) shares closed up 11.49% at $0.30 GH Research ... 
Tags Benzinga Movers Cannabis
From Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On ... 
Tags BYSI BIIB IMV
From Benzinga
A Recap of How Psychedelics Fared in 2021
From InvestorBrandNetwork
Why Jim Cramer Likes Illumina And Enterprise Products Partners
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) has got "unbelievable ... 
Tags ATAI Small Cap EPD
From Benzinga
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the... 
Tags Market News
From TalkMarkets
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous ... 
Tags MNMD General psychedelics
From Benzinga
Analysts Anticipate KOMP Will Reach $80
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD
All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD? 
Tags Pharma/Biotech Market News Stocks / Equities
From TalkMarkets
The Year In Review For Psychedelic Drug Stocks: 2021
2021 was two different "years" for the psychedelic drug industry. Impressive progress in drug R&D and clinics; stocks pushed down to absurdly lean multiples. 
Tags Market News Stocks / Equities Pharma/Biotech
From TalkMarkets
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ... 
Tags Partner Content News Penny Stocks
From Benzinga
46 Biggest Movers From Yesterday
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. ... 
Tags NXTD TRT BSN
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services ... 
Tags ALZN Intraday Update IMAB
From Benzinga
Dow Down Triple Digits as Fed Meeting Wraps Up
Stocks have deepened their morning losses by midday, with the Dow Jones Industrial Average down 119 points, while both the Nasdaq Composite and S&P 500 Index are firmly in the red as well. 
Tags Stocks / Equities Market News
From TalkMarkets
Mid-Morning Market Update: Markets Open Lower; US Retail Sales Miss Estimates
Following the market opening Wednesday, the Dow traded down 0.26% to 35,453.17 while the NASDAQ fell 0.62% to 15,142.70. The S&P ... 
Tags ZLAB Market News CCMP
From Benzinga
North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
Image provided by Flickr The following post was written and/or published as a collaboration between Benzinga’s in-house ... 
Tags Penny Stocks Biotech ATAI
From Benzinga
Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
Photo by Raimond Klavins on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ... 
Tags MCUR Mind Cure Health Inc/ Penny Stocks
From Benzinga
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same... 
Tags Pharma/Biotech Stocks / Equities Market News
From TalkMarkets
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
Psilerais a Florida-based biotechnology company focused on developing drugs to treat mental disorders using non-hallucinogenic ... 
Tags Benzinga News CYBN
From Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis bypartnering ... 
Tags Government Penny Stocks ATAI Life Sciences
From Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.